{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:36:29Z","timestamp":1774604189233,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FIPE\/HCPA-Brazil"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.tiv.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T18:16:07Z","timestamp":1551982567000},"page":"194-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine"],"prefix":"10.1016","volume":"57","author":[{"given":"Tatiane Cristina","family":"Hauschild","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilian","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Paula","family":"Mescka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella Moura","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinara Jaqueline","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanusa","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Regla","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2019.03.007_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","article-title":"Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain","volume":"1324","author":"Amaral","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0010","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","article-title":"Reduction of large neutral amino acid level in plasma and brain of hyperleucinemic rats","volume":"38","author":"Ara\u00fajo","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tiv.2019.03.007_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-006-9030-5","article-title":"Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease","volume":"21","author":"Barschak","year":"2006","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijdevneu.2007.05.004","article-title":"Erythrocyte glutathione peroxidase activity and plasma selenium concentration are reduced in maple syrup urine disease patients during treatment","volume":"25","author":"Barschak","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11011-007-9077-y","article-title":"Oxidative stress in plasma from maple syrup urine disease patients during treatment","volume":"23","author":"Barschak","year":"2008","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.clinbiochem.2007.11.015","article-title":"Maple syrup urine disease in treated patients: biochemical and oxidative stress profiles","volume":"41","author":"Barschak","year":"2008","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.clinbiochem.2008.12.005","article-title":"Amino acids levels and lipid peroxidation in maple syrup urine disease patients","volume":"42","author":"Barschak","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/nep.12977","article-title":"Globotriaosylsphingosine induces oxidative DNA damage in cultured kidney cells","volume":"22","author":"Biancini","year":"2017","journal-title":"Nephrology"},{"key":"10.1016\/j.tiv.2019.03.007_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","article-title":"Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease","volume":"21","author":"Bridi","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11011-005-4152-8","article-title":"Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defenses in cerebral cortex from young rats","volume":"20","author":"Bridi","year":"2005","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10715760400022350","article-title":"Evaluation of the mechanism involved in leucine-induced oxidative damage in cerebral cortex of young rats","volume":"39","author":"Bridi","year":"2005","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0060","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1971","article-title":"Maple syrup urine disease (branched chain ketoaciduria)","author":"Chuang","year":"2001"},{"key":"10.1016\/j.tiv.2019.03.007_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbagen.2013.04.022","article-title":"Measuring oxidative damage to DNA and its repair with the comet assay","volume":"1840","author":"Collins","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2019.03.007_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cca.2005.09.009","article-title":"Does measurement of oxidative damage to DNA have clinical significance?","volume":"365","author":"Cooke","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tiv.2019.03.007_bb0075","first-page":"595","article-title":"L-carnitine protects gastric mucosa by decreasing ischemia-reperfusion induced lipid peroxidation","volume":"55","author":"Derin","year":"2004","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11010-014-2322-x","article-title":"Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria","volume":"402","author":"Dos Santos Mello","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1320.007","article-title":"Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review","volume":"1033","author":"Ferrari","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mrgentox.2011.02.005","article-title":"Vargas, DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients; protective effect of enzyme replacement therapy","volume":"721","author":"Filippon","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","article-title":"Stimulation of lipid peroxidation in vitro in rat brain by metabolites accumulating in maple syrup urine disease","volume":"17","author":"Fontella","year":"2002","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0100","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","article-title":"Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach","volume":"112","author":"Frazier","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tiv.2019.03.007_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijdevneu.2015.02.003","article-title":"Urinary biomarkers of oxidative damage in maple syrup urine disease: the L-carnitine role","volume":"42","author":"Guerreiro","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0110","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","article-title":"Antioxidant and antiradical activities of l-carnitine","volume":"78","author":"G\u00fcl\u00e7in","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00204-011-0774-2","article-title":"Antioxidant activity of food constituents: an overview","volume":"86","author":"G\u00fcl\u00e7in","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0120","series-title":"Free Radicals in Biology and Medicine","first-page":"230","author":"Halliwell","year":"2007"},{"key":"10.1016\/j.tiv.2019.03.007_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbrc.2003.11.007","article-title":"Mechanisms responsible for regulation of branched-chain amino acid catabolism","volume":"313","author":"Harris","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2019.03.007_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/mutage\/18.1.45","article-title":"Recommendations for conducting the in vivo alkaline comet assay","volume":"18","author":"Hartmann","year":"2003","journal-title":"Mutagenesis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1203\/01.pdr.0000190571.60385.34","article-title":"Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD","volume":"59","author":"Hoffmann","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000071709","article-title":"Effect of L-carnitine on carrageenan-induced inflammation in aged rats","volume":"49","author":"Izg\u00fct-Uysal","year":"2003","journal-title":"Gerontology."},{"key":"10.1016\/j.tiv.2019.03.007_bb0145","series-title":"HPLC of Small Peptides","first-page":"13","article-title":"Amino acids and small peptides","author":"Joseph","year":"1986"},{"key":"10.1016\/j.tiv.2019.03.007_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2009.02.016","article-title":"The comet assay: a sensitive method for detecting DNA damage in individual cells","volume":"48","author":"Liao","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.tiv.2019.03.007_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijdevneu.2015.03.004","article-title":"Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients","volume":"43","author":"Marchetti","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijdevneu.2012.10.109","article-title":"Protein and lipid damage in maple syrup urine disease patients: L-carnitine effect","volume":"31","author":"Mescka","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.gene.2014.07.051","article-title":"Prevention of DNA damage by L-carnitine induced y metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro","volume":"548","author":"Mescka","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.tiv.2019.03.007_bb0170","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s11011-015-9686-9","article-title":"Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation","volume":"30","author":"Mescka","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2015.03.008","article-title":"L-Carnitine supplementation decreases DNA damage in treated MSUD patients","volume":"775","author":"Mescka","year":"2015","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0180","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1007\/s12035-015-9500-z","article-title":"L-carnitine prevents oxidative stress in the brains of rats subjected to a chemically induced chronic model of MSUD","volume":"53","author":"Mescka","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jns.2010.01.016","article-title":"Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain","volume":"292","author":"Moraes","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/002215540104900912","article-title":"A silver staining method for single-cell gel assay","volume":"49","author":"Nadin","year":"2001","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymgme.2013.11.011","article-title":"In vitro effect of genistein on DNA damage in leukocytes from mucopolysaccharidosis IVA patients","volume":"111","author":"Negretto","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.tiv.2019.03.007_bb0200","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1373\/clinchem.2007.098434","article-title":"Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)","volume":"54","author":"Oglesbee","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijdevneu.2010.01.002","article-title":"Reduction of lipid and protein damage in patients with disorders of propionate metabolism under treatment: a possible protective role of L-carnitine supplementation","volume":"28","author":"Ribas","year":"2010","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10571-011-9736-8","article-title":"Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L-carnitine supplementation","volume":"32","author":"Ribas","year":"2012","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.gene.2013.10.017","article-title":"L-carnitine supplementation as a potencial antioxidant therapy for inherited neurometabolic diseases","volume":"533","author":"Ribas","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.tiv.2019.03.007_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tiv.2017.04.006","article-title":"Experimental evidence of oxidative stress in patients with l-2-hydroxyglutaric aciduria and that l-carnitine attenuates in vitro DNA damage caused by d-2-hydroxyglutaric and l-2-hydroxyglutaric acids","volume":"42","author":"Rodrigues","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2019.03.007_bb0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2014.06.014","article-title":"Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease","volume":"70","author":"Sanders","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tiv.2019.03.007_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ymgme.2012.04.009","article-title":"DNA damage in an animal model of maple syrup urine disease","volume":"106","author":"Scaini","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tiv.2019.03.007_bb0235","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/clinchem\/45.10.1734","article-title":"Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease","volume":"45","author":"Schadewaldt","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.tiv.2019.03.007_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2004.01.016","article-title":"Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease","volume":"82","author":"Schonberger","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tiv.2019.03.007_bb0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mrgentox.2009.07.013","article-title":"Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients","volume":"679","author":"Sitta","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2019.03.007_bb0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10571-010-9636-3","article-title":"Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients","volume":"31","author":"Sitta","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0260","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10571-013-0002-0","article-title":"Neurological damage in MSUD: the role of oxidative stress","volume":"34","author":"Sitta","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2478\/s11658-009-0036-y","article-title":"The antioxidant properties of carnitine in vitro","volume":"15","author":"Solarska","year":"2010","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.tiv.2019.03.007_bb0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11940-003-0039-3","article-title":"Branched-chain ketoacyl dehydrogenase deficiency: maple syrup disease","volume":"5","author":"Strauss","year":"2003","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.tiv.2019.03.007_bb0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-510X(00)00402-0","article-title":"Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease","volume":"181","author":"Tavares","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.tiv.2019.03.007_bb0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice","year":"2000","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.tiv.2019.03.007_bb0285","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/B:BOLI.0000037353.13085.e2","article-title":"The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies","volume":"27","author":"Wajner","year":"2004","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233318307355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233318307355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T12:02:30Z","timestamp":1606651350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233318307355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":57,"alternative-id":["S0887233318307355"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2019.03.007","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}